BKYI
BIO-key International, Inc.
BKYI lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
BKYI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
BKYI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BKYI PE Valuation
BKYI has no meaningful PE right now: it lost money over the past year.
BKYI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BKYI's losses to shrink, with revenue growing.
BKYI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.93 | +$3.37 |
| Q1 2026 | -$9.37 | +$9.93 |
| Q4 2025 | -$10.77 | +$10.13 |
| Q3 2025 | -$8.90 | +$53.20 |
| Q2 2025 | -$11.30 | +$59.50 |
| Q1 2025 | -$19.30 | +$70.30 |
| Q4 2024 | -$20.90 | +$70.90 |
| Q3 2024 | -$62.10 | +$135.55 |
BKYI lost $7.93 per share over the past year, a smaller loss than the year before.
BKYI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.9M | +13% |
| Q1 2026 | $2.1M | +33% |
| Q4 2025 | $1.1M | -26% |
| Q3 2025 | $1.5M | -28% |
| Q2 2025 | $1.7M | +49% |
| Q1 2025 | $1.6M | -26% |
| Q4 2024 | $1.5M | -20% |
| Q3 2024 | $2.1M | +18% |
BKYI's revenue is recovering but still below its 2023 peak: $2M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | +36 points |
| Q1 2026 | -7.3% | +33 points |
| Q4 2025 | -389% | -302 points |
| Q3 2025 | -58% | -31 points |
| Q2 2025 | -64% | +81 points |
| Q1 2025 | -40% | -17 points |
| Q4 2024 | -87% | +63 points |
| Q3 2024 | -27% | +15 points |
BKYI's operating margin was −28% last quarter, up 36 points from the same quarter a year ago.
BKYI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$845.7K | +$35.7K |
| Q1 2026 | -$358K | +$481.9K |
| Q4 2025 | -$1.8M | -$1.3M |
| Q3 2025 | -$1.1M | +$173.1K |
| Q1 2025 | -$839.9K | -383% |
| Q4 2024 | -$504.6K | +$1M |
| Q3 2024 | -$1.3M | -$1.1M |
| Q1 2024 | $297.1K | +$2.2M |
BKYI has burned cash in almost every quarter: −$4M over the past year, against −$4M the year before.
BKYI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2K shares |
| 1 year | +121% | +567K shares |
| 3 years | +2191% | +992K shares |
| 5 years | +7058% | +1M shares |
BKYI has 1M diluted shares, up 121% from a year ago.
BKYI Net Leverage
BKYI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BKYI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 29.9 | Neutral |
BKYI's weekly RSI is 42 (neutral) and its Stochastic is 30 (neutral).
BKYI PE vs Industrials Sector
BKYI has no meaningful PE right now: it lost money over the past year.
BKYI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.41 | 7.1% above |
| 20 week MA | $3.16 | 18% below |
| 50 week MA | $4.70 | 45% below |
| 100 week MA | $7.00 | 63% below |
| 200 week MA | $33.8 | 92% below |
BKYI has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 92% below its 200-week average.
BKYI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $705.9 | $624.6 | -12% |
| 2021 | $624.6 | $417.6 | -33% |
| 2022 | $417.6 | $108.1 | -74% |
| 2023 | $108.1 | $30.0 | -72% |
| 2024 | $30.0 | $14.1 | -53% |
| 2025 | $14.1 | $6.06 | -57% |
| 2026 YTD | $6.06 | $2.58 | -57% |
BKYI has finished every year since 2020 lower, and it's down 57% so far in 2026.